Literature DB >> 28639061

Oral and oropharyngeal papillomas are not associated with high-risk human papillomavirus infection.

Miroslaw Snietura1, Roman Lamch2, Agnieszka Kopec2, Dariusz Waniczek3, Wirginia Likus4, Dariusz Lange2, Jaroslaw Markowski5.   

Abstract

The role of different types of human papillomavirus (HPV) in the development of oral and oropharyngeal papillomas remains unclear. High-risk HPV (HR-HPV) was shown to be involved in the pathogenesis of significant proportion of squamous cell carcinomas of the oropharynx. In this study, we hypothesized that in some oropharyngeal papillomas, low-risk HPV (LR-HPV) and HR-HPV infection could co-exist, similar to what is observed in genital warts, and thus contribute to the elevated risk of malignancy. To test this hypothesis, we used real-time PCR to assess the presence of HPV DNA of 16 types (2 LR-HPV and 14 HR-HPV), in 75 formalin-fixed and paraffin-embedded histopathological samples of oral and oropharyngeal papillomas and in 57 squamous cell carcinomas from the same regions. We investigated the biological activity of HPV by demonstrating accumulation of P16(INK4A) protein in the viral-infected tissue samples. The presence of the LR-HPV genome from the HPV6 or HPV11 types was confirmed in 42 (56%) papillomas and in no carcinomas. HPV6/HPV11 co-infection was detected in 17 (22.7%) of the papillomas. HR-HPV DNA presence and HR-HPV activity hallmarks were not observed in any of the investigated papillomas. Thus, a causative role for HR-HPV or its contribution to LR/HR-HPV co-infection in the pathogenesis of oral or oropharyngeal papillomas is unlikely. Additionally, HR-HPV and LR-HPV infections seem to be mutually exclusive in papillomas and squamous cell carcinomas of the oral cavity and oropharynx.

Entities:  

Keywords:  Human papillomavirus; Oropharyngeal cancer; Pharyngeal papilloma; Pharyngeal warts

Mesh:

Substances:

Year:  2017        PMID: 28639061     DOI: 10.1007/s00405-017-4649-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  23 in total

1.  Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.

Authors:  Gabriella M Anic; Ji-Hyun Lee; Heather Stockwell; Dana E Rollison; Yougui Wu; Mary R Papenfuss; Luisa L Villa; Eduardo Lazcano-Ponce; Christine Gage; Roberto José C Silva; Maria L Baggio; Manuel Quiterio; Jorge Salmerón; Martha Abrahamsen; Anna R Giuliano
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

2.  P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.

Authors:  Jeroen J Mooren; Sibel E Gültekin; Jos M J A A Straetmans; Annick Haesevoets; Carine J Peutz-Kootstra; Christian U Huebbers; Hans P Dienes; Ulrike Wieland; Frans C S Ramaekers; Bernd Kremer; Ernst-Jan M Speel; Jens P Klussmann
Journal:  Int J Cancer       Date:  2013-10-21       Impact factor: 7.396

3.  Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts.

Authors:  Maria Blomberg; Soren Friis; Christian Munk; Andrea Bautz; Susanne K Kjaer
Journal:  J Infect Dis       Date:  2012-03-15       Impact factor: 5.226

4.  Natural history of genital warts.

Authors:  J D Oriel
Journal:  Br J Vener Dis       Date:  1971-02

Review 5.  Papilloma viruses in cancers and papillomas of the aerodigestive tract.

Authors:  E M de Villiers
Journal:  Biomed Pharmacother       Date:  1989       Impact factor: 6.529

6.  Epidemiology of otorhinolaryngological squamous cell papillomas in a Spanish subpopulation during a 20 year period.

Authors:  M Lopez Amado; I Castro Lareo; A Lozano Ramirez; L Caballero Torcuato
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  1996

7.  Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers.

Authors:  Bostjan J Kocjan; Polona J Maver; Lea Hosnjak; Nina Zidar; Katarina Odar; Nina Gale; Mario Poljak
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2012-12

8.  Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas.

Authors:  Maria Gabriella Donà; Barbara Pichi; Francesca Rollo; Tarik Gheit; Valentina Laquintana; Renato Covello; Edoardo Pescarmona; Giuseppe Spriano; Raul Pellini; Massimo Giuliani; Massimo Tommasino; Maria Benevolo
Journal:  Head Neck       Date:  2016-09-12       Impact factor: 3.147

9.  Cancer risk among patients with condylomata acuminata.

Authors:  Caroline Nordenvall; Ellen T Chang; Hans-Olov Adami; Weimin Ye
Journal:  Int J Cancer       Date:  2006-08-15       Impact factor: 7.396

10.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

Authors:  Suzanne M Garland; Marc Steben; Heather L Sings; Margaret James; Shuang Lu; Radha Railkar; Eliav Barr; Richard M Haupt; Elmar A Joura
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

View more
  3 in total

1.  The Prevalence, Anatomic Distribution and Significance of HPV Genotypes in Head and Neck Squamous Papillomas as Detected by Real-Time PCR and Sanger Sequencing.

Authors:  A Trzcinska; W Zhang; M Gitman; W H Westra
Journal:  Head Neck Pathol       Date:  2019-07-27

2.  Radiofrequency VS Cold Surgery to Treat Oral Papillomatous Lesions.

Authors:  Bruno Galletti; Francesco Gazia; Cosimo Galletti; Francesco Freni; Cosimo Galletti; Rocco Bruno; Federico Sireci; Francesco Galletti
Journal:  Iran J Otorhinolaryngol       Date:  2021-03

3.  Detection of human papillomavirus DNA in formalin-fixed, paraffin-embedded squamous papillomas of the oral cavity.

Authors:  Jack Daigrepont; Jennifer E Cameron; Kelly L Wright; Kitrina G Cordell; Molly S Rosebush
Journal:  J Clin Exp Dent       Date:  2018-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.